An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

Abroad (travel likely)RecruitingPHASE2

Conditions

Bipolar I Disorder · Mania

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Neurocrine Clinical Site, Garden Grove, California, United States
Neurocrine Clinical Site, Hollywood, California, United States
Neurocrine Clinical Site, San Diego, California, United States
Neurocrine Clinical Site, Atlanta, Georgia, United States
Neurocrine Clinical Site, Gaithersburg, Maryland, United States
Neurocrine Clinical Site, Marlton, New Jersey, United States

Study leads

Clinical Development Lead
Study Director
Neurocrine Biosciences

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders

Bipolar Disorder · Cannabis Use · Schizoaffective Disorder, Bipolar Type

Abroad (travel likely)RecruitingPHASE2

Charleston, United States

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

Bipolar I Disorder · Bipolar II Disorder

Abroad (travel likely)RecruitingPHASE2

Huntsville, United States · Chandler, United States

Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder

Bipolar I Disorder · Depression, Anxiety · Stress

Abroad (travel likely)RecruitingPHASE2

Belmont, United States

Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.

Bipolar I Disorder

Abroad (travel likely)RecruitingPHASE2

Bentonville, United States · Little Rock, United States